An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Public ClinicalTrials.gov record NCT02082197. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is an open-study with a 26 week open label treatment period followed by an optional 26 week open label extension. The total treatment period will be 52 weeks.
Study identification
- NCT ID
- NCT02082197
- Recruitment status
- Withdrawn
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2014 (Type not available)
- Primary completion
- Jun 2015 (Estimated)
- Completion
- Jun 2015 (Estimated)
- Last update posted
- Jun 2, 2014
2014 – 2015
United States locations
- U.S. sites
- 42
- U.S. states
- 21
- U.S. cities
- 40
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site Reference ID/Investigator# 124163 | Birmingham | Alabama | 35213 | — |
| Site Reference ID/Investigator# 123938 | Huntsville | Alabama | 35801 | — |
| Site Reference ID/Investigator# 125782 | Mesa | Arizona | 85202 | — |
| Site Reference ID/Investigator# 124157 | Phoenix | Arizona | 85032 | — |
| Site Reference ID/Investigator# 123937 | Tucson | Arizona | 85712 | — |
| Site Reference ID/Investigator# 123948 | Anaheim | California | 92801 | — |
| Site Reference ID/Investigator# 124164 | Los Angeles | California | 90069 | — |
| Site Reference ID/Investigator# 123920 | Los Gatos | California | 95032 | — |
| Site Reference ID/Investigator# 124038 | Colorado Springs | Colorado | 80907-0000 | — |
| Site Reference ID/Investigator# 126202 | Denver | Colorado | 80218 | — |
| Site Reference ID/Investigator# 123927 | Middlebury | Connecticut | 06762-1835 | — |
| Site Reference ID/Investigator# 123947 | Clearwater | Florida | 33756 | — |
| Site Reference ID/Investigator# 123929 | Jacksonville | Florida | 32216 | — |
| Site Reference ID/Investigator# 123940 | Ocala | Florida | 34471 | — |
| Site Reference ID/Investigator# 124166 | Orlando | Florida | 32806 | — |
| Site Reference ID/Investigator# 123945 | Ponte Vedra Beach | Florida | 32081 | — |
| Site Reference ID/Investigator# 123930 | Dunwoody | Georgia | 30338 | — |
| Site Reference ID/Investigator# 124395 | Wichita | Kansas | 67226 | — |
| Site Reference ID/Investigator# 125784 | Crestview Hills | Kentucky | 41017 | — |
| Site Reference ID/Investigator# 123919 | Lexington | Kentucky | 40509 | — |
| Site Reference ID/Investigator# 123925 | Baltimore | Maryland | 21287 | — |
| Site Reference ID/Investigator# 123936 | Methuen | Massachusetts | 01844 | — |
| Site Reference ID/Investigator# 124160 | Las Vegas | Nevada | 89121 | — |
| Site Reference ID/Investigator# 123939 | Las Vegas | Nevada | 89148 | — |
| Site Reference ID/Investigator# 123932 | Lawrenceville | New Jersey | 08648 | — |
| Site Reference ID/Investigator# 123943 | Albuquerque | New Mexico | 87106 | — |
| Site Reference ID/Investigator# 123926 | Garden City | New York | 11530 | — |
| Site Reference ID/Investigator# 125783 | New York | New York | 10016 | — |
| Site Reference ID/Investigator# 123928 | Poughkeepsie | New York | 12601 | — |
| Site Reference ID/Investigator# 124165 | Charlotte | North Carolina | 28209 | — |
| Site Reference ID/Investigator# 123933 | Morehead City | North Carolina | 28557 | — |
| Site Reference ID/Investigator# 123921 | Salisbury | North Carolina | 28144 | — |
| Site Reference ID/Investigator# 124162 | Cleveland | Ohio | 44122 | — |
| Site Reference ID/Investigator# 123917 | Bala-Cynwyd | Pennsylvania | 19004 | — |
| Site Reference ID/Investigator# 123931 | Jenkintown | Pennsylvania | 19046 | — |
| Site Reference ID/Investigator# 123924 | Greer | South Carolina | 29651 | — |
| Site Reference ID/Investigator# 123895 | Chattanooga | Tennessee | 37411 | — |
| Site Reference ID/Investigator# 123946 | Nashville | Tennessee | 37203 | — |
| Site Reference ID/Investigator# 123923 | Austin | Texas | 78705-2660 | — |
| Site Reference ID/Investigator# 123922 | Dallas | Texas | 75231 | — |
| Site Reference ID/Investigator# 124167 | Dallas | Texas | 75231 | — |
| Site Reference ID/Investigator# 123944 | San Antonio | Texas | 78218 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02082197, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 2, 2014 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02082197 live on ClinicalTrials.gov.